Drug Development, Hospitals and Process Improvement

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Development

Hospitals

Process Improvement

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

Drug Development

Drug Development Immunity Immunization Pharmaceutical Companies

Data and digital is a force to reckon with when it comes to India

Express Pharma

OCTOBER 31, 2024

She highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to harnessing India’s vast talent pool, particularly in the scientific and medical fields, in an interview with Viveka Roychowdhury India seems to have become a hub for pharma GCCs. With a long gestation period.

Drug Development

Drug Development Hospitals Process Improvement Documentation

Pharmacist Digest

Developing a first-in-class small molecule drug for inflammatory disease

Data and digital is a force to reckon with when it comes to India

Stay Connected